Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
69%
Antiinfective Agent
57%
Malignant Neoplasm
57%
Prevalence
46%
Antibiotics
46%
Diabetes Mellitus
40%
Antibiotic Resistance
34%
Antimicrobial Agent
33%
Cross-Sectional Study
32%
Tablet
30%
Bioavailability
29%
Infection
28%
Rat
28%
Adverse Event
26%
Antioxidant
26%
Warfarin
25%
microRNA
24%
Cardiovascular Disease
24%
Cross-Sectional Study
22%
Pharmacokinetic
21%
Retrospective Study
21%
Cohort Study
21%
Nanoparticle
21%
Global Disease Burden
20%
Anti-Inflammatory Drug
20%
Comorbidity
18%
Inflammation
17%
Chitosan
17%
Cross Sectional Study
16%
Vancomycin
16%
Coronavirinae
15%
SARS Coronavirus
15%
Drug Interaction
14%
Side Effect
14%
Drug Release
14%
Neoplasm
13%
Doxorubicin
13%
Clinical Trial
13%
Inflammatory Arthritis
13%
Rheumatoid Arthritis
13%
Lipid
13%
Transcription Factor Nrf2
13%
Observational Study
12%
FDA Adverse Event Reporting System
12%
Anticoagulant Agent
12%
Pandemic
12%
Gentamicin
12%
Chronic Disease
12%
Escherichia coli
12%
Breast Cancer
11%
Drug Delivery System
11%
Pharmacotherapy
11%
Nanoemulsion
11%
Surgical Infection
11%
Pterostilbene
11%
Resveratrol
11%
COVID-19 Vaccine
10%
Brain Ischemia
10%
Community Pharmacy
10%
Nanomaterial
10%
Adverse Drug Reaction
10%
Differential Scanning Calorimetry
10%
Enzyme
10%
Hemoglobin A1c
9%
Surgical Prophylaxis
9%
IC50
9%
High Performance Liquid Chromatography
9%
Adverse Effect
9%
Drug-Drug Interaction
9%
Eudragit
9%
Combination Therapy
9%
Klebsiella pneumoniae
9%
CYP2C9
9%
Liver Cell Carcinoma
9%
Congestive Heart Failure
9%
Phytochemical
9%
Medication Error
8%
Scanning Electron Microscopy
8%
Cerebrovascular Accident
8%
Piroxicam
8%
Controlled Release
8%
Hydroxychloroquine
8%
Atrial Fibrillation
8%
Silibinin
8%
Dexibuprofen
8%
Rosuvastatin
8%
Diabetic Cardiomyopathy
8%
Ebastine
8%
Thymoquinone
8%
Antimicrobial Resistance
8%
Dosage Form
8%
Acinetobacter Baumannii
8%
Bacterium
8%
Poloxamer
7%
Parkinson's Disease
7%
Antidiabetic Agent
7%
Vaccination
7%
Essential Oil
7%
Cisplatin
7%
Reverse Phase High Performance Liquid Chromatography
7%
Nursing and Health Professions
Saudi Arabia
100%
Cross-Sectional Study
41%
Diseases
36%
Health Care Personnel
31%
Quality of Life
31%
Warfarin
31%
Diabetes Mellitus
26%
Prevalence
25%
Antimicrobial Stewardship
24%
Systematic Review
22%
COVID-19
20%
Adherence
17%
Antiinfective Agent
17%
Quality of Life
16%
Pakistan
15%
Chronic Disease
15%
Cohort Analysis
14%
Cross-Sectional Study
14%
Rheumatoid Arthritis
14%
Inflammatory Arthritis
14%
Patient with Diabetes
13%
Health Care Cost
13%
Tertiary Care Center
12%
Medication Compliance
12%
Pharmacy Student
11%
Practice Guideline
11%
Meta Analysis
11%
Cardiovascular Disease
10%
Primary Health Care
10%
Antibiotic Resistance
10%
Antimicrobial Agent
10%
Chronic Condition
10%
Blood Pressure
10%
Infection
10%
Medication Therapy Management
10%
Patient Compliance
9%
Accident Prevention
9%
Medication Error
9%
Education
9%
Health Care Utilization
9%
Health Care
9%
Emergency Ward
8%
World Health Organization
8%
Adverse Event
8%
Intensive Care Unit
8%
Hypertension
8%
Anticoagulation
8%
Vancomycin
8%
Patient with Type 2 Diabetes
7%
Comorbidity
7%
International Normalized Ratio
7%
Propensity Score
7%
Odds Ratio
7%
Breast Cancer
7%
Patient Attitude
7%
Malignant Neoplasm
7%
Inferential Statistics
6%
Logistic Regression Analysis
6%
Anticoagulant Therapy
6%
Clinical Outcome
6%
Community Pharmacist
6%
Public Health
6%
Medication Therapy Management Service
6%
Anticoagulant Agent
6%
Hospital Readmission
6%
Confidence Interval
6%
Public Hospital
6%
Professional Standard
6%
Congestive Heart Failure
6%
Clinical Pharmacist
6%
Treatment Outcome
5%
Cross-Sectional Survey
5%
Cost Effectiveness Analysis
5%
Telemedicine
5%
Patient-Reported Outcome
5%
Consumer Attitude
5%
Medline
5%
Efficacy
5%
Primary Care Physician
5%
Surgical Infection
5%
Medicine and Dentistry
COVID-19
38%
Diabetes
27%
Diseases
26%
Cross Sectional Study
23%
Global Disease Burden
21%
Prevalence
20%
Health Care Cost
19%
Diabetes Mellitus
17%
Systematic Review
17%
Quality of Life
15%
Maturity Onset Diabetes of the Young
13%
Infection
12%
Malignant Neoplasm
11%
Breast Cancer
11%
Antibiotic Resistance
11%
Retrospective Cohort Study
11%
Cardiovascular Disease
11%
Patient with Type 2 Diabetes
9%
Drug Therapy
8%
Odds Ratio
8%
Observational Study
7%
Tertiary Care
7%
Meta-Analysis
7%
Patient with Diabetes
7%
Antibiotics
7%
Cardiovascular System
7%
Life Expectancy
6%
Comorbidity
6%
Hypertension
6%
microRNA
6%
Disability Adjusted Life Years
6%
Logistic Regression Analysis
6%
Antimicrobial Agent
6%
Community Pharmacy
6%
Propensity Score Matching
6%
Cancer Cell
6%
Apoplexy
6%
Retrospective Study
5%
Pediatrics Patient
5%
Health Care Personnel
5%
Pediatrics
5%
Complementary and Alternative Medicine
5%
Lung Cancer
5%
Drug Resistant Tuberculosis
5%
Oral
5%
Medication Therapy Management Service
5%
Body Mass Index
5%
Patient Compliance
5%
Neoplasm
5%
Cancer Therapy
5%
Programmed Cell Death
5%